Zhang, L; Prietsch, SO; Axelsson, I; Halperin, SA (17 de septiembre de 2014). «Acellular vaccines for preventing whooping cough in children.». The Cochrane Database of Systematic Reviews9: CD001478. PMID25228233. doi:10.1002/14651858.CD001478.pub6.
«Acellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection». Drugs52 (2): 254-275. Aug 1996. PMID8841742. doi:10.2165/00003495-199652020-00010.
Cherry JD (1990). «'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is». J Am Med Assoc263 (12): 1679-80. PMID2308206. doi:10.1001/jama.263.12.1679.
Evans G (2006). «Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002». Clin Infect Dis. 42 Suppl 3: S130-7. PMID16447135. doi:10.1086/499592.
«Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults». J Am Med Assoc293 (24): 3003-11. June 2005. PMID15933223. doi:10.1001/jama.293.24.3003.
«Vaccine, Pentavalent». International Drug Price Indicator Guide. Archivado desde el original el 30 de diciembre de 2017. Consultado el 8 de diciembre de 2015.
Zhang, L; Prietsch, SO; Axelsson, I; Halperin, SA (17 de septiembre de 2014). «Acellular vaccines for preventing whooping cough in children.». The Cochrane Database of Systematic Reviews9: CD001478. PMID25228233. doi:10.1002/14651858.CD001478.pub6.
Kline, JM; Lewis, WD; Smith, EA; Tracy, LR; Moerschel, SK (15 de octubre de 2013). «Pertussis: a reemerging infection.». American Family Physician88 (8): 507-14. PMID24364571.
«Acellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection». Drugs52 (2): 254-275. Aug 1996. PMID8841742. doi:10.2165/00003495-199652020-00010.
Cherry JD (1990). «'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is». J Am Med Assoc263 (12): 1679-80. PMID2308206. doi:10.1001/jama.263.12.1679.
Evans G (2006). «Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002». Clin Infect Dis. 42 Suppl 3: S130-7. PMID16447135. doi:10.1086/499592.
«Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults». J Am Med Assoc293 (24): 3003-11. June 2005. PMID15933223. doi:10.1001/jama.293.24.3003.
«Vaccine, Pentavalent». International Drug Price Indicator Guide. Archivado desde el original el 30 de diciembre de 2017. Consultado el 8 de diciembre de 2015.
«Pertussis Vaccines:WHO Position Paper». August 2015. Archivado desde el original el 4 de marzo de 2016. «It is plausible that in humans, as in nonhuman primates, asymptomatic or mildly symptomatic infections in DTaP-immunized persons may result in transmission of B. pertussis to others and may drive pertussis outbreaks.»
«Pertussis Vaccines:WHO Position Paper». August 2015. Archivado desde el original el 4 de marzo de 2016. «It is plausible that in humans, as in nonhuman primates, asymptomatic or mildly symptomatic infections in DTaP-immunized persons may result in transmission of B. pertussis to others and may drive pertussis outbreaks.»